Literature DB >> 1650466

Autoradiographic localization of relaxin binding sites in rat brain.

P L Osheroff1, H S Phillips.   

Abstract

Relaxin is a member of the insulin family of polypeptide hormones and exerts its best understood actions in the mammalian reproductive system. Using a biologically active 32P-labeled human relaxin, we have previously shown by in vitro autoradiography specific relaxin binding sites in rat uterus, cervix, and brain tissues. Using the same approach, we describe here a detailed localization of human relaxin binding sites in the rat brain. Displaceable relaxin binding sites are distributed in discrete regions of the olfactory system, neocortex, hypothalamus, hippocampus, thalamus, amygdala, midbrain, and medulla of the male and female rat brain. Characterization of the relaxin binding sites in the subfornical organ and neocortex reveals a single class of high-affinity sites (Kd = 1.4 nM) in both regions. The binding of relaxin to two of the circumventricular organs (subfornical organ and organum vasculosum of the lamina terminalis) and the neurosecretory magnocellular hypothalamic nuclei (i.e., paraventricular and supraoptic nuclei) provides the anatomical and biochemical basis for emerging physiological evidence suggesting a central role for relaxin in the control of blood pressure and hormone release. We conclude that specific, high-affinity relaxin binding sites are present in discrete regions of the rat brain and that the distribution of some of these sites may be consistent with a role for relaxin in control of vascular volume and blood pressure.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1650466      PMCID: PMC52095          DOI: 10.1073/pnas.88.15.6413

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  33 in total

1.  Bioassay of relaxin using a reference standard: a simple and reliable method utilizing direct measurement of interpubic ligament formation in mice.

Authors:  B G STEINETZ; V L BEACH; R L KROC; N R STASILLI; R E NUSSBAUM; P J NEMITH; R K DUN
Journal:  Endocrinology       Date:  1960-07       Impact factor: 4.736

2.  Lack of evidence of a vasodepressor role for relaxin in spontaneously hypertensive and normotensive pregnant rats.

Authors:  R A Ahokas; B M Sibai; G D Anderson
Journal:  Am J Obstet Gynecol       Date:  1989-09       Impact factor: 8.661

3.  Lesion of the subfornical organ affects the haemotensive response to centrally administered relaxin in anaesthetized rats.

Authors:  A D Mumford; L J Parry; A J Summerlee
Journal:  J Endocrinol       Date:  1989-09       Impact factor: 4.286

Review 4.  Relaxin in the male.

Authors:  G Weiss
Journal:  Biol Reprod       Date:  1989-02       Impact factor: 4.285

Review 5.  Relaxin.

Authors:  B E Kemp; H D Niall
Journal:  Vitam Horm       Date:  1984       Impact factor: 3.421

6.  Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction.

Authors:  Y Cheng; W H Prusoff
Journal:  Biochem Pharmacol       Date:  1973-12-01       Impact factor: 5.858

7.  Bidirectional transport of interleukin-1 alpha across the blood-brain barrier.

Authors:  W A Banks; A J Kastin; D A Durham
Journal:  Brain Res Bull       Date:  1989-12       Impact factor: 4.077

8.  Receptor autoradiographic analysis of insulin-like growth factor-I (IGF-I) binding sites in rat forebrain and pituitary gland.

Authors:  K Matsuo; M Niwa; M Kurihara; K Shigematsu; S Yamashita; M Ozaki; S Nagataki
Journal:  Cell Mol Neurobiol       Date:  1989-09       Impact factor: 5.046

9.  Increases in heart rate and blood pressure produced by microinjections of atrial natriuretic factor into the AV3V region of rat brain.

Authors:  M A Sills; K Q Nguyen; D M Jacobowitz
Journal:  Peptides       Date:  1985 Nov-Dec       Impact factor: 3.750

10.  Relaxin affects the release of oxytocin and vasopressin from the neurohypophysis.

Authors:  G Dayanithi; M Cazalis; J J Nordmann
Journal:  Nature       Date:  1987 Feb 26-Mar 4       Impact factor: 49.962

View more
  13 in total

Review 1.  Relaxin and fibrosis: Emerging targets, challenges, and future directions.

Authors:  Anthony J Kanai; Elisa M Konieczko; Robert G Bennett; Chrishan S Samuel; Simon G Royce
Journal:  Mol Cell Endocrinol       Date:  2019-02-14       Impact factor: 4.102

Review 2.  Relaxin family peptide systems and the central nervous system.

Authors:  G E Callander; R A D Bathgate
Journal:  Cell Mol Life Sci       Date:  2010-03-07       Impact factor: 9.261

3.  Quantitative autoradiographic studies of relaxin binding in rat atria, uterus and cerebral cortex: characterization and effects of oestrogen treatment.

Authors:  Y Y Tan; J D Wade; G W Tregear; R J Summers
Journal:  Br J Pharmacol       Date:  1999-05       Impact factor: 8.739

4.  Inotropic responses to human gene 2 (B29) relaxin in a rat model of myocardial infarction (MI): effect of pertussis toxin.

Authors:  Andrew R Kompa; Chrishan S Samuel; Roger J Summers
Journal:  Br J Pharmacol       Date:  2002-11       Impact factor: 8.739

5.  Relaxin peptide hormones are protective during the early stages of ischemic stroke in male rats.

Authors:  Lindsay H Bergeron; Jordan M Willcox; Faisal J Alibhai; Barry J Connell; Tarek M Saleh; Brian C Wilson; Alastair J S Summerlee
Journal:  Endocrinology       Date:  2014-12-02       Impact factor: 4.736

6.  Circulating relaxin acts on subfornical organ neurons to stimulate water drinking in the rat.

Authors:  N Sunn; M Egli; T C D Burazin; P Burns; L Colvill; P Davern; D A Denton; B J Oldfield; R S Weisinger; M Rauch; H A Schmid; M J McKinley
Journal:  Proc Natl Acad Sci U S A       Date:  2002-02-05       Impact factor: 11.205

7.  Primate relaxin: synthesis of gorilla and rhesus monkey relaxins.

Authors:  J D Wade; S S Layden; P F Lambert; H Kakouris; G W Tregear
Journal:  J Protein Chem       Date:  1994-04

8.  Relaxin binding in the rat heart atrium.

Authors:  P L Osheroff; M J Cronin; J A Lofgren
Journal:  Proc Natl Acad Sci U S A       Date:  1992-03-15       Impact factor: 11.205

9.  Altered relaxin family receptors RXFP1 and RXFP3 in the neocortex of depressed Alzheimer's disease patients.

Authors:  Jasinda H Lee; Shu Qing Koh; Simone Guadagna; Paul T Francis; Margaret M Esiri; Christopher P Chen; Peter T-H Wong; Gavin S Dawe; Mitchell K P Lai
Journal:  Psychopharmacology (Berl)       Date:  2015-11-06       Impact factor: 4.530

10.  Immunoexpression of the relaxin receptor LGR7 in breast and uterine tissues of humans and primates.

Authors:  Richard Ivell; Marga Balvers; Yvonne Pohnke; Ralph Telgmann; Olaf Bartsch; Karin Milde-Langosch; Ana-Maria Bamberger; Almuth Einspanier
Journal:  Reprod Biol Endocrinol       Date:  2003-11-24       Impact factor: 5.211

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.